Literature DB >> 23764957

Longitudinal interviews of couples diagnosed with diminished ovarian reserve undergoing fragile X premutation testing.

Lisa M Pastore1, Logan B Karns, Karen Ventura, Myra L Clark, Richard H Steeves, Nancy Callanan.   

Abstract

About 10 % of infertile/subfertile women are diagnosed with diminished ovarian reserve (DOR), of which < 5 % will become pregnant spontaneously. Fragile X (FMR1) genetic testing may provide a reason for her early ovarian aging and/or have reproductive implications. Seven women with DOR (genetic study subset) and the male partners of six of these women were separately interviewed about the experience of being asked to undergo this unanticipated genetic test. Three interviews were conducted (before, within 1 week after, and 3 months after learning the test results). None of the participants carried the FMR1 premutation (largest FMR1 allele 27-50 CGG repeats). For women, their pregnancy-seeking journey was long and exhausting. Women understood the reproductive implications of carrying the FMR1 premutation, and hoped for a negative result. Being offered a genetic test caused women to pause and re-think their future reproductive plans. Husbands viewed the infertility journey as filled with unknowns, of which the genetic test results would be one more puzzle piece. The expense of fertility testing/treatment was mentioned by both spouses, though more notably by husbands. The introduction of a possible genetic cause of infertility, with additional potential health consequences for future biological children, caused women to re-think their quest for pregnancy. In contrast, the genetic test was viewed as an additional source of information for their husbands as opposed to raising concern regarding potential reproductive ramifications.

Entities:  

Mesh:

Year:  2013        PMID: 23764957      PMCID: PMC3800506          DOI: 10.1007/s10897-013-9616-0

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  44 in total

1.  Familial transmission of the FMR1 CGG repeat.

Authors:  S L Nolin; F A Lewis; L L Ye; G E Houck; A E Glicksman; P Limprasert; S Y Li; N Zhong; A E Ashley; E Feingold; S L Sherman; W T Brown
Journal:  Am J Hum Genet       Date:  1996-12       Impact factor: 11.025

2.  Partners of mutation-carriers for Huntington's disease: forgotten persons?

Authors:  Marleen Decruyenaere; Gerry Evers-Kiebooms; Andrea Boogaerts; Koen Demyttenaere; René Dom; Jean-Pierre Fryns
Journal:  Eur J Hum Genet       Date:  2005-09       Impact factor: 4.246

3.  Expensive but worth it: older parents' attitudes and opinions about the costs and insurance coverage for in vitro fertilization.

Authors:  Robert D Nachtigall; Kirstin MacDougall; Anne C Davis; Yewoubdar Beyene
Journal:  Fertil Steril       Date:  2011-11-25       Impact factor: 7.329

4.  Sample size in qualitative research.

Authors:  M Sandelowski
Journal:  Res Nurs Health       Date:  1995-04       Impact factor: 2.228

Review 5.  The FMR1 premutation and reproduction.

Authors:  Michael D Wittenberger; Randi J Hagerman; Stephanie L Sherman; Allyn McConkie-Rosell; Corrine K Welt; Robert W Rebar; Emily C Corrigan; Joe Leigh Simpson; Lawrence M Nelson
Journal:  Fertil Steril       Date:  2006-10-30       Impact factor: 7.329

6.  Fragile X AGG analysis provides new risk predictions for 45-69 repeat alleles.

Authors:  Sarah L Nolin; Sachin Sah; Anne Glicksman; Stephanie L Sherman; Emily Allen; Elizabeth Berry-Kravis; Flora Tassone; Carolyn Yrigollen; Amy Cronister; Marcia Jodah; Nicole Ersalesi; Carl Dobkin; W Ted Brown; Raghav Shroff; Gary J Latham; Andrew G Hadd
Journal:  Am J Med Genet A       Date:  2013-02-26       Impact factor: 2.802

7.  Paternal transmission of fragile X syndrome.

Authors:  Susan Zeesman; Lonnie Zwaigenbaum; Donald T Whelan; Randi J Hagerman; Flora Tassone; Sherryl A M Taylor
Journal:  Am J Med Genet A       Date:  2004-08-30       Impact factor: 2.802

8.  The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm.

Authors:  E Reyniers; L Vits; K De Boulle; B Van Roy; D Van Velzen; E de Graaff; A J Verkerk; H Z Jorens; J K Darby; B Oostra
Journal:  Nat Genet       Date:  1993-06       Impact factor: 38.330

9.  Apparent regression of the CGG repeat in FMR1 to an allele of normal size.

Authors:  L Vits; K De Boulle; E Reyniers; I Handig; J K Darby; B Oostra; P J Willems
Journal:  Hum Genet       Date:  1994-11       Impact factor: 4.132

10.  Fragile X syndrome: diagnostic and carrier testing.

Authors:  Stephanie Sherman; Beth A Pletcher; Deborah A Driscoll
Journal:  Genet Med       Date:  2005-10       Impact factor: 8.822

View more
  3 in total

1.  Attitudes towards potentially carrying the FMR1 premutation: before vs after testing of non-carrier females with diminished ovarian reserve.

Authors:  Lisa M Pastore; Maria Antero; Karen Ventura; J Kim Penberthy; Semara A Thomas; Logan B Karns
Journal:  J Genet Couns       Date:  2014-05-03       Impact factor: 2.537

2.  Patients' preimplantation genetic testing decision-making experience: an opinion on related psychological frameworks.

Authors:  L M Pastore; C N Cordeiro Mitchell; L R Rubin; J Nicoloro-SantaBarbara; M C Genoff Garzon; M Lobel
Journal:  Hum Reprod Open       Date:  2019-10-04

Review 3.  The FMR1 gene, infertility, and reproductive decision-making: a review.

Authors:  Lisa M Pastore; Joshua Johnson
Journal:  Front Genet       Date:  2014-07-07       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.